MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable,
related party-Related...
$232,298
Cash
$4,578
Prepaid expenses
$200
Total current assets
$237,076
Total assets
$237,076
Retained earnings
(deficit)
-$22,659,473
Other comprehensive
income
-$222,580
Total liabilities &
stockholders equity...
$237,076
Total stockholders
equity (deficit)
-$6,572,997
Additional paid in capital
$16,297,234
Common stock (.0001 par
value) 5,800,000,000...
$10,806
Preferred stock,
value-Series APreferred...
$1,011
Preferred stock,
value-Series MPreferred...
$3
Preferred stock,
value-Series NCPreferred...
$2
Total liabilities
$6,810,073
Total current
liabilities
$6,810,073
Derivative liability
$2,460,443
Accrued expenses
$1,852,221
Unearned income
$1,306,971
Convertible notes payable,
net of unamortized...
$947,132
Notes
payable-Related Party
$132,504
Other current
liabilities
$99,776
Accounts payable
$11,024
Back
Back
Balance Sheet
source: myfinsight.com
Regen BioPharma Inc (RGBPP)
Regen BioPharma Inc (RGBPP)